Thursday, 27 August, 2026
Smart Medicine: Huawei Bets Big on AI-Powered Drug Discovery
By TechShots Studio
Following tech rivals into the lucrative AI health market, Huawei is expanding its pharmaceutical partnerships to accelerate drug research. Powered by its Ascend and Kunpeng chips, Huawei provides specialized AI tools to optimize target discovery and screen drug compounds. Collaborating with domestic drugmakers like Guangzhou Pharmaceutical, Huawei aims to leverage machine learning to potentially cut early-stage drug development timelines and costs in half.